Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Asks Supreme Court To Drop Gilead False Claims Case

Executive Summary

The US Solicitor General is advising the Supreme Court not to hear a suit challenging whether a False Claims Act suit can be brought if the government knows about the alleged misbehavior and continues to pay for the relevant products or services.

You may also be interested in...



US High Court Won’t Hear FCA, Patent Cases

The US Supreme Court announced Monday that it won’t hear a much-watched case that could have limited the government’s ability to bring False Claims Act cases if it knew of the alleged misconduct. Two drug-world patent cases were also declined.

What Did The Government Know, And When Did Know It? US Supreme Court Seeks Views On False-Claims Case

The US Solicitor General was asked to weigh in on Gilead's petition asking the high court to clarify application of its Escobar decision. Trade groups say FDA, not a jury, should decide whether a company has complied with the Food, Drug and Cosmetic Act.

Pharma Industry Broadens Its Approach To Expanded Access

Novartis co-leads industry forum on preapproval access that aims to share best practices and engage patient groups; Janssen is launching three pilots to leverage collection of preapproval access data.

Topics

Related Companies

UsernamePublicRestriction

Register

MT124357

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel